Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 4
2009 8
2010 1
2011 7
2012 4
2013 2
2014 1
2015 4
2016 4
2017 1
2018 3
2019 2
2021 9
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
Romine JK, Li H, Coughlin MM, Jones JM, Britton A, Tyner HL, Fuller SB, Bloodworth R, Edwards LJ, Etoule JN, Morrill TC, Newes-Adeyi G, Olsho LEW, Gaglani M, Fowlkes A, Hollister J, Bedrick EJ, Uhrlaub JL, Beitel S, Sprissler RS, Lyski Z, Porter CJ, Rivers P, Lutrick K, Caban-Martinez AJ, Yoon SK, Phillips AL, Naleway AL, Burgess JL, Ellingson KD. Romine JK, et al. Among authors: fowlkes a. Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093/cid/ciae130. Online ahead of print. Clin Infect Dis. 2024. PMID: 38466720
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.
Rivers P, Porter C, LeClair LB, Jeddy Z, Fowlkes AL, Lamberte JM, Herder K, Smith M, Rai R, Grant L, Hegmann KT, Jovel K, Vaughan M, Mathenge C, Phillips AL, Khan S, Britton A, Pilishvili T, Burgess JL, Newes-Adeyi G, Gaglani M, Caban-Martinez A, Yoon S, Lutrick K; PROTECT network. Rivers P, et al. Among authors: fowlkes al. Vaccine. 2024 Mar 7;42(7):1512-1520. doi: 10.1016/j.vaccine.2024.01.016. Epub 2024 Feb 2. Vaccine. 2024. PMID: 38307743 Free article.
Influenza incidence, lineages, and vaccine effectiveness estimates in Lima, Peru, 2023.
Acevedo-Rodriguez JG, Zamudio C, Kojima N, Krapp F, Tsukayama P, Sal Y Rosas Celi VG, Baldeon D, Neciosup-Vera CS, Medina C, Gonzalez-Lagos E, Castro L, Fowlkes A, Azziz-Baumgartner E, Gotuzzo E; PISAAC working group. Acevedo-Rodriguez JG, et al. Among authors: fowlkes a. Lancet Microbe. 2024 Apr;5(4):e308-e309. doi: 10.1016/S2666-5247(23)00392-0. Epub 2024 Jan 11. Lancet Microbe. 2024. PMID: 38219756 Free PMC article. No abstract available.
Effectiveness of COVID-19 vaccines against hospitalisation in Latin America during three pandemic waves, 2021-2022: a test-negative case-control design.
Nogareda F, Regan AK, Couto P, Fowlkes AL, Gharpure R, Loayza S, Leite JA, Rodríguez A, Vicari A, Azziz-Baumgartner E, Salas D; REVELAC-i Working Group. Nogareda F, et al. Among authors: fowlkes al. Lancet Reg Health Am. 2023 Nov 10;27:100626. doi: 10.1016/j.lana.2023.100626. eCollection 2023 Nov. Lancet Reg Health Am. 2023. PMID: 38035125 Free PMC article.
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies.
Hollister J, Caban-Martinez AJ, Ellingson KD, Beitel S, Fowlkes AL, Lutrick K, Tyner HL, Naleway AL, Yoon SK, Gaglani M, Hunt D, Meece J, Mayo Lamberte J, Schaefer Solle N, Rose S, Dunnigan K, Khan SM, Kuntz JL, Fisher JM, Coleman A, Britton A, Thiese MS, Hegmann KT, Pavuk M, Ramadan FA, Fuller S, Nematollahi A, Sprissler R, Burgess JL. Hollister J, et al. Among authors: fowlkes al. Environ Res. 2023 Dec 15;239(Pt 1):117297. doi: 10.1016/j.envres.2023.117297. Epub 2023 Oct 8. Environ Res. 2023. PMID: 37816422 Free article.
Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections.
Quirk GE, Schoenle MV, Peyton KL, Uhrlaub JL, Lau B, Burgess JL, Ellingson K, Beitel S, Romine J, Lutrick K, Fowlkes A, Britton A, Tyner HL, Caban-Martinez AJ, Naleway A, Gaglani M, Yoon S, Edwards L, Olsho L, Dake M, LaFleur BJ, Nikolich JŽ, Sprissler R, Worobey M, Bhattacharya D. Quirk GE, et al. Among authors: fowlkes a. medRxiv [Preprint]. 2023 Sep 14:2023.09.12.23295384. doi: 10.1101/2023.09.12.23295384. medRxiv. 2023. PMID: 37745498 Free PMC article. Preprint.
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.
Fowlkes AL, Nogareda F, Regan A, Loayza S, Mancio JM, Duca LM, Couto P, Leite J, Rodriguez A, Salas D, Azziz-Baumgartner E; REVELAC–i Network. Fowlkes AL, et al. MMWR Morb Mortal Wkly Rep. 2023 Sep 15;72(37):1010-1015. doi: 10.15585/mmwr.mm7237e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37708084 Free PMC article. No abstract available.
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5-11 Years in a Multisite Prospective Cohort Study, September 2021-September 2022.
Lyski ZL, Porter C, Uhrlaub JL, Ellingson KD, Jeddy Z, Gwynn L, Rivers P, Sprissler R, Hegmann KT, Coughlin M, Fowlkes A, Hollister J, LeClair L, Mak J, Beitel SC, Fuller S, Grant L, Newes-Adeyi G, Yoo YM, Olsho L, Burgess JL, Caban-Martinez A, Yoon S, Britton A, Gaglani M, Lutrick K. Lyski ZL, et al. Among authors: fowlkes a. Open Forum Infect Dis. 2023 Aug 12;10(8):ofad431. doi: 10.1093/ofid/ofad431. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37663086 Free PMC article.
End-of-season influenza vaccine effectiveness during the Southern Hemisphere 2022 influenza season - Chile, Paraguay, and Uruguay.
Chard AN, Nogareda F, Regan AK, Barraza MFO, Fasce RA, Vergara N, Avendaño M, Penayo E, Vázquez C, Von Horoch M, Michel F, Alfonso A, Mogdasy C, Chiparelli H, Goñi N, Alegretti M, Loayza S, Couto P, Rodriguez A, Salas D, Fowlkes AL, Azziz-Baumgartner E. Chard AN, et al. Among authors: fowlkes al. Int J Infect Dis. 2023 Sep;134:39-44. doi: 10.1016/j.ijid.2023.05.015. Epub 2023 May 16. Int J Infect Dis. 2023. PMID: 37201863 Free PMC article.
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
Ellingson KD, Hollister J, Porter CJ, Khan SM, Feldstein LR, Naleway AL, Gaglani M, Caban-Martinez AJ, Tyner HL, Lowe AA, Olsho LEW, Meece J, Yoon SK, Mak J, Kuntz JL, Solle NS, Respet K, Baccam Z, Wesley MG, Thiese MS, Yoo YM, Odean MJ, Miiro FN, Pickett SL, Phillips AL, Grant L, Romine JK, Herring MK, Hegmann KT, Lamberte JM, Sokol B, Jovel KS, Thompson MG, Rivers P, Pilishvili T, Lutrick K, Burgess JL, Midgley CM, Fowlkes AL. Ellingson KD, et al. Among authors: fowlkes al. Emerg Infect Dis. 2023 Mar;29(3):599-604. doi: 10.3201/eid2903.221314. Epub 2023 Jan 26. Emerg Infect Dis. 2023. PMID: 36703252 Free PMC article.
69 results